Eli Lilly and CompanyLLYNYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 18.87% |
| Q3 2025 | -1.38% |
| Q2 2025 | 105.14% |
| Q1 2025 | -37.43% |
| Q4 2024 | 354.48% |
| Q3 2024 | -67.30% |
| Q2 2024 | 32.28% |
| Q1 2024 | 2.43% |
| Q4 2023 | 3914.81% |
| Q3 2023 | -103.26% |
| Q2 2023 | 31.10% |
| Q1 2023 | -30.59% |
| Q4 2022 | 33.48% |
| Q3 2022 | 52.41% |
| Q2 2022 | -49.94% |
| Q1 2022 | 10.24% |
| Q4 2021 | 55.49% |
| Q3 2021 | -20.15% |
| Q2 2021 | 2.58% |
| Q1 2021 | -35.97% |
| Q4 2020 | 75.17% |
| Q3 2020 | -14.42% |
| Q2 2020 | -3.06% |
| Q1 2020 | -2.62% |
| Q4 2019 | 19.28% |
| Q3 2019 | -5.52% |
| Q2 2019 | -68.71% |
| Q1 2019 | 277.03% |
| Q4 2018 | -2.13% |
| Q3 2018 | 542.29% |
| Q2 2018 | -121.35% |
| Q1 2018 | 173.47% |
| Q4 2017 | -398.22% |
| Q3 2017 | -44.88% |
| Q2 2017 | 1009.75% |
| Q1 2017 | -114.36% |
| Q4 2016 | -0.80% |
| Q3 2016 | 4.05% |
| Q2 2016 | 69.89% |
| Q1 2016 | -8.01% |